Mike Ward, Clarivate’s Global Head of Thought Leadership, Life Sciences and Healthcare, joined a fireside chat with Sean Marett, Chief Business and Commercial Officer at BioNTech at 2nd annual European HealthTech CEO Forum, to deconstruct the Pfizer-BioNtech deal to develop and distribute Tozinameran, the first COVID-19 vaccine approved worldwide. Mike and Sean discuss pivotal moments in the development of the first-to-finish COVID-19 vaccine: